Marcelo Arthur Dias da Costa Santana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marcelo Arthur Dias da Costa Santana has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Adenilza da Silva Barbosa
HRL-SES-PE/ HUOC-UPE
1 shared publication - Aldeiza Mariano de Lima
UNP - Polo Pau dos Ferros - RN
1 shared publication - Ana Helena Pequeno Câmara
EBSERH/MEJC
1 shared publication - Ana Luiza da Silva Godeiro
EBSERH/HUOL-UFRN
1 shared publication - Aryane Lucia da Silva Aguiar De Oliveira
Laboratory of Drug Design and Synthesis (LPSF), Nucleus of Research in Therapeutic Innovation (NUPIT‐SG), Center of Biosciences Federal University of Pernambuco Recife Brazil
1 shared publication - Bruno Basilio Cardoso de Lima
UNINASSAU, Caruaru – PE, Brasil
1 shared publication
Latest Publications
- Open Access
- 30 August 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (33) , e74190
Dengue Virus Molecular Targets and Antiviral Drug Development: Advances, Challenges and Therapeutic Perspectives
Dengue is the most prevalent arboviral disease in tropical and subtropical regions, with over 13 million cases recorded in the Americas in 2024. Despite its enormous public health impact, no specific antiviral therapy is currently approved for dengue virus (DENV). In this context, this narrative review critically analyses the principal molecular targets of DENV, including structural proteins (C, prM/M and E), nonstructural proteins (NS1–NS5) and host factors, with emphasis on the development of small‐molecule antivirals and an evaluation of their progress in pre‐clinical and clinical studies. The NS2B–NS3 protease complex and NS5 (both RdRp and MTase domains) remain the most extensively explored targets, owing to the availability of high‐resolution crystal structures and higher inter‐serotype conservation. NS4B has emerged as the most clinically advanced target. Among direct‐acting antivirals, AT‐752 was also discontinued due to low viraemia at enrolment, while NITD‐688 remains among the most advanced pipeline molecules. Host‐directed therapies including anakinra and baricitinib are under clinical investigation for severe dengue. Key translational challenges include viral serotype diversity, pharmacokinetic limitations, cytotoxicity, and the timing of treatment initiation relative to viral kinetics. Advances in rational drug design, drug repurposing, allosteric inhibition, and targeted protein degradation (PROTACs) offer renewed perspectives for effective dengue therapeutics.
- 30 August 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (33) , e74190
Open AccessDengue Virus Molecular Targets and Antiviral Drug Development: Advances, Challenges and Therapeutic Perspectives
Dengue is the most prevalent arboviral disease in tropical and subtropical regions, with over 13 million cases recorded in the Americas in 2024. Despite its enormous public health impact, no specific antiviral therapy is currently approved for dengue virus (DENV). In this context, this narrative review critically analyses the principal molecular targets of DENV, including structural proteins (C, prM/M and E), nonstructural proteins (NS1–NS5) and host factors, with emphasis on the development of small‐molecule antivirals and an evaluation of their progress in pre‐clinical and clinical studies. The NS2B–NS3 protease complex and NS5 (both RdRp and MTase domains) remain the most extensively explored targets, owing to the availability of high‐resolution crystal structures and higher inter‐serotype conservation. NS4B has emerged as the most clinically advanced target. Among direct‐acting antivirals, AT‐752 was also discontinued due to low viraemia at enrolment, while NITD‐688 remains among the most advanced pipeline molecules. Host‐directed therapies including anakinra and baricitinib are under clinical investigation for severe dengue. Key translational challenges include viral serotype diversity, pharmacokinetic limitations, cytotoxicity, and the timing of treatment initiation relative to viral kinetics. Advances in rational drug design, drug repurposing, allosteric inhibition, and targeted protein degradation (PROTACs) offer renewed perspectives for effective dengue therapeutics.
- Open Access
- 31 July 2023
- Published by Brazilian Journal of Implantology and Health Sciences in Brazilian Journal of Implantology and Health Sciences
- Vol. 5 (4) , 2530-2541
COVID-19, FAKE NEWS E VACINAÇÃO: OS DESAFIOS ENFRENTADOS NA SAÚDE PÚBLICA
The Covid-19 pandemic caused the disease to spread rapidly across all continents and spread various positive and negative information, which circulated or circulated on the internet, presenting different content. The objective of this study is to inform the population about the Fake News approach and the spread of misinformation and the challenges that public health faces. Studies were carried out from secondary sources, through bibliographic research in scientific databases, in the time window from 2021 to 2023, with the most recent and compatible articles prevailing. Eleven complete and published articles were found, related to vaccination against Covid-19, Fake News associated with the vaccination process and the influence on the population's adherence to immunizations in the context of public health. The Covid-19 pandemic, which was characterized by the acute respiratory syndrome popularly known as SARS-CoV-2, which resulted in several deaths due to lack of vaccination and also generated the infodemic and misinformation pandemic, where society began to discredit science and credibility it had. continentes e propagou diversas informações positivas e negativas, que circulam ou circularam na internet apresentando conteúdos diversos. O Objetivo deste estudo é informar a população sobre a abordagem de Fake News e a propagação da desinformação e os desafios que saúde pública enfrenta. Foram realizados estudos a partir de fontes secundárias, por meio da pesquisa bibliográfica em bancos de dados científicos, na janela temporal de 2021 a 2023, prevalecendo os artigos mais recentes e compatível. Encontrou-se onze artigos completos e publicados, relacionados à vacinação contra a Covid-19, Fake News associadas ao processo vacinal e a influência na adesão da população aos imunizantes no contexto de saúde pública. A pandemia de Covid-19 que foi caracterizada pela síndrome respiratória aguda popularmente conhecida como SARS-CoV-2, que obtive diversas mortes por falta de vacinação e também gerou a pandemia da infodemia e desinformação, onde a sociedade começou a desacreditar nas ciências e na credibilidade que a mesma tinha.
- 31 July 2023
- Published by Brazilian Journal of Implantology and Health Sciences in Brazilian Journal of Implantology and Health Sciences
- Vol. 5 (4) , 2530-2541
Open AccessCOVID-19, FAKE NEWS E VACINAÇÃO: OS DESAFIOS ENFRENTADOS NA SAÚDE PÚBLICA
The Covid-19 pandemic caused the disease to spread rapidly across all continents and spread various positive and negative information, which circulated or circulated on the internet, presenting different content. The objective of this study is to inform the population about the Fake News approach and the spread of misinformation and the challenges that public health faces. Studies were carried out from secondary sources, through bibliographic research in scientific databases, in the time window from 2021 to 2023, with the most recent and compatible articles prevailing. Eleven complete and published articles were found, related to vaccination against Covid-19, Fake News associated with the vaccination process and the influence on the population's adherence to immunizations in the context of public health. The Covid-19 pandemic, which was characterized by the acute respiratory syndrome popularly known as SARS-CoV-2, which resulted in several deaths due to lack of vaccination and also generated the infodemic and misinformation pandemic, where society began to discredit science and credibility it had. continentes e propagou diversas informações positivas e negativas, que circulam ou circularam na internet apresentando conteúdos diversos. O Objetivo deste estudo é informar a população sobre a abordagem de Fake News e a propagação da desinformação e os desafios que saúde pública enfrenta. Foram realizados estudos a partir de fontes secundárias, por meio da pesquisa bibliográfica em bancos de dados científicos, na janela temporal de 2021 a 2023, prevalecendo os artigos mais recentes e compatível. Encontrou-se onze artigos completos e publicados, relacionados à vacinação contra a Covid-19, Fake News associadas ao processo vacinal e a influência na adesão da população aos imunizantes no contexto de saúde pública. A pandemia de Covid-19 que foi caracterizada pela síndrome respiratória aguda popularmente conhecida como SARS-CoV-2, que obtive diversas mortes por falta de vacinação e também gerou a pandemia da infodemia e desinformação, onde a sociedade começou a desacreditar nas ciências e na credibilidade que a mesma tinha.